Cord blood banking is defined as the collection and storage of stem cells present within the umbilical cord blood of a newborn for future medical use. Umbilical cord blood is rich in a type of stem cell known as a hematopoietic stem cell (HSC). A large market for the storage of these cells has come into existence over the past 30 years, with public and private cord blood banks now present in all major healthcare markets worldwide. [Read more…]
BioStem Life Sciences, Inc., Subsidiary of BioStem Technologies, Inc., Announces Entry into Market with Four Amniotic Products
Pompano Beach, FL, Oct. 01, 2018 — BioStem Life Sciences (“Life Sciences” or the “Company”), a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM), a Company focused on the development of the highest quality placental-based amniotic tissue products, whose mission is to create a new paradigm of healthcare, using breakthrough therapies that treat patients who otherwise are without effective treatment options, announced today that it has entered the market with four placental-derived tissue products for multiple indications within the ophthalmology, orthopedic and advanced wound care markets. [Read more…]
Amniotic Stem Cells: An Extension of the Cord Blood Banking Model
Amniotic stem cells, which can be sourced from the amniotic fluid or the placenta after a live, healthy birth, possess a unique blend of multipotency and lack of tumorigenicity. In an extension of the cord blood banking model, these cells may improve outcomes where long-term cell survival and functionality is important. Recently, I had the honor of interview Dr. Todd McAllister, Executive Director at the Amnion Foundation, a non-profit organization with the mission to build a genetically diverse public cell bank that can provide an immunological match to the majority of the population.
In this interview, we discuss the Amnion Foundation’s vision, research and clinical approach, scale-out strategy, and interest in joint partnerships that will support greater utilization of amniotic stem cells. It is captivating to get an insider look at the Amnion Foundation, a non-profit that is introducing a new extension to the traditional cord blood and tissue banking market.
As the cord blood banking market matures and consolidates and diversifies into new types of perinatal stem cell storage, the Amnion Foundation will be uniquely positioned to advise cord blood banks on how to integrate amniotic stem cell banking into their service portfolio.
Top 10 Quotes from the Perinatal Stem Cell Society Conference 2016
Over the past three days, dozens of world renowned speakers have presented their latest findings at the Perinatal Stem Cell Society Conference 2016, hosted by Kyle Cetrulo of Auxocell Laboratories and the Perinatal Stem Cell Society (IPLASS).
To capture the best moments from the conference, below are the top 10 quotes from the event, which was hosted at Aspen Meadows Resort in Aspen, CO, over March 2-4, 2016.
I took the image above as we were landing in Aspen. You can see our full photo album from the event on Flickr, featuring presenters, sponsors, and more.
To get live updates from the event, connect with me on Twitter (@StemCellMarket) or follow the hashtag #Perinatal. Enjoy! [Read more…]